Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/69/51/7c/69517cfe-cd26-8ab0-f6ca-8a0afee0cb94/mza_10402012418079449467.png/600x600bb.jpg
Gynecologic Oncology Update
Dr. Neil Love
30 episodes
4 days ago
This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
Show more...
Science
Education,
Health & Fitness,
Medicine
RSS
All content for Gynecologic Oncology Update is the property of Dr. Neil Love and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
Show more...
Science
Education,
Health & Fitness,
Medicine
https://artwork.captivate.fm/aa2bde68-0d40-4e41-b73e-fff33f9524cf/gou-podcast-logo-3000px.png
Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
Gynecologic Oncology Update
1 hour 5 minutes 36 seconds
1 year ago
Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.
Gynecologic Oncology Update
This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.